---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-030043"
form_type: "8-K"
ticker: "CRMD"
cik: "0001410098"
company_name: "CorMedix Inc."
filed_at: "2023-04-17T23:59:59+00:00"
generated_at: "2026-06-17T01:17:52.150511+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CorMedix appoints Robert Stewart to Board of Directors

## Summary
- Robert Stewart appointed to Board effective April 13, 2023; Board now has 8 directors, 7 independent.
- Stewart is CEO of Theramex; former CEO of Amneal Pharma and COO of Allergan.
- Received initial option for 25,000 shares (1/3 vesting at grant, then annually); additional prorated option for 14,200 shares.
- Stewart's experience expected to aid CorMedix's transition from development to commercial phase, per CEO.
- Press release highlights commercial potential for lead product DefenCath.

## SEC filing metadata
- accession: 0001213900-23-030043
- form_type: 8-K
- ticker: CRMD
- cik: 0001410098
- company_name: CorMedix Inc.
- filed_at: 2023-04-17T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1410098/000121390023030043/0001213900-23-030043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1410098/000121390023030043/ea177005-8k_cormedix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-030043
- JSON: https://secwatch.observer/filing/0001213900-23-030043.json
- Plain text: https://secwatch.observer/filing/0001213900-23-030043.txt

## Key facts
- Executive change
  Robert Stewart was appointed as Director at CorMedix Inc..
  - Action: appointed
  - Role: Director
  source text: On April 13, 2023, the Board of Directors (the “Board”) of CorMedix Inc. (the “Company”) appointed Robert Stewart as a director, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1410098/000121390023030043/0001213900-23-030043-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.